Cyberkinetics - Neurotechnology Systems, Inc.


		View Text-Only page




Pending Humanitarian Device Exemption. Not available for sale in the United States. Effectiveness has not been demonstrated for this use.

CYBERKINETICS’ ANDARA™ OFS™ THERAPY FEATURED IN PRESENTATIONS AT THE AANS/CNS MEETING
Researchers report that people with spinal cord injuries treated with Cyberkinetics’ Andara™ OFS™ System showed significantly greater neurological improvement than those in a separate study who received no therapy for their spinal cord injuries.

Cyberkinetics' Andara™ Oscillating Field Stimulator (OFS™) Device technology platform is being developed to regenerate nerve tissue to restore sensory and motor function lost due to spinal cord injuries and a wide range of nervous system injuries, diseases and conditions. Cyberkinetics is also developing the Andara™ OFS™ PLUS System, which combines the use of the device with the simultaneous application of drug therapy, to enable the treatment of nerve injuries that are months to years old.

Cyberkinetics' NeuroPort™ and BrainGate Systems are based on the same direct neural sensing technology platform. The FDA 510(k)-cleared NeuroPort™ System is being developed to enable physicians to provide a new tool that may improve understanding about how the brain works and may enable more accurate diagnosis and treatment of central nervous system injuries and conditions. The BrainGate System is being developed to provide novel communication interfaces, the ability to control devices and to potentially restore limb movement to those with spinal cord injury, stroke, ALS (Lou Gehrig's disease), as well as other central nervous system injuries.

Designed & Developed by Embarc, Inc.
Photography by Rick Friedman Photography